BioSpace News Archive

Nobelpharma America, LLC has initiated distribution of HYFTOR™ (sirolimus topical gel) 0.2% into the United States healthcare marketplace.

Rafa Laboratories LTD. (" Rafa ") is pleased to announce the U.S. Food and Drug Administration has approved its “first in market” 10 mg midazolam autoinjector for the treatment of status epilepticus in adults.

Aria Pharmaceuticals announced that the company has successfully filed a total of six provisional patents with the United States Patent and Trademark Office (USPTO) for lead candidates in its lupus, idiopathic pulmonary fibrosis (IPF), and chronic kidney disease (CKD) research programs.

Veeva Systems (NYSE: VEEV) today announced that Veranex is using Veeva Vault CDMS to speed study builds and simplify clinical data management.

Ionis Pharmaceuticals, Inc. announced that management will participate in fireside chats at the following investor conferences.

MAIA Biotechnology, Inc. today announced that it has been selected to conduct an oral presentation covering the novel THIO platform at the XIV International Round Table on Nucleosides, Nucleotides, and Nucleic Acids, which will be taking place in Stockholm, Sweden on August 28 – 31, 2022.

Aptose Biosciences Inc. today announced that the Aptose management team will participate in the H.C. Wainwright 24th Annual Global Investment Conference being held in-person and virtually September 12-14, 2022, in New York City.

AIM ImmunoTech Inc. today announced its clinical development collaborator, Roswell Park Comprehensive Cancer Center (“Roswell Park”), in a clinical trial fully funded by the National Cancer Institute (NCI), has commenced patient enrollment in its Phase 2 study in subjects with primary PD-1/PD-L1 resistant melanoma.

Arbutus Biopharma Corporation today announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,427,823, which provides composition of matter patent protection for Arbutus’ AB-729 RNAi therapeutic product.

Frequency Therapeutics, Inc. today announced that members of its management team will participate in investor and medical conferences later this month.